Application no. and date | 17153799.6 (espacenet) (Federated) (European Patent Register), 20111209 | Patent/reg. no. and date | DK/EP 3214091, 20181003 | Publication date | 20170906 | Priority no. and date | US 421470 P, 20101209, US 201161502649 P, 20110629 | EP pub. no. and date |
EP 3214091 20170906 | Effective date | | Applicant/owner | The Trustees of The University of Pennsylvania, Center for Technology Transfer 3160 Chestnut Street, Suite 200 Philadelphia, PA 19104-6283, US | Applicant ref. no. | P23768DKEP | Inventor | JUNE, Carl H., 409 Baird Road
Merion Station, PA 19066, US, MILONE, Michael C., 314 Surrey Road
Cherry Hill, NJ 08002, US, LEVINE, Bruce L., 1258 Liberty Bell Drive
Cherry Hill, NJ 08003, US, KALOS, Michael D., 716 Carpenter Lane
Philadelphia, PA 19119, US, PORTER, David L., 821 Crum Creek Road
Springfield, PA 19064, US | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 39/00 (2006.01) , C07H 21/04 (2006.01) | Title | ANVENDELSE AF KIMÆRE ANTIGENRECEPTORMODIFICEREDE T-CELLER TIL BEHANDLING AF CANCER | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2019 00007 | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|